Zions Bancorporation N.A. lifted its position in Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) by 19.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 14,265 shares of the semiconductor company's stock after buying an additional 2,303 shares during the period. Zions Bancorporation N.A.'s holdings in Silicon Laboratories were worth $1,772,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. Jones Financial Companies Lllp increased its holdings in Silicon Laboratories by 44.5% in the 4th quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company's stock worth $28,000 after buying an additional 69 shares in the last quarter. Advisors Asset Management Inc. increased its position in Silicon Laboratories by 159.4% during the third quarter. Advisors Asset Management Inc. now owns 275 shares of the semiconductor company's stock valued at $32,000 after acquiring an additional 169 shares during the last quarter. Venturi Wealth Management LLC lifted its holdings in Silicon Laboratories by 207.0% in the fourth quarter. Venturi Wealth Management LLC now owns 786 shares of the semiconductor company's stock valued at $98,000 after acquiring an additional 530 shares during the period. Asset Management One Co. Ltd. bought a new position in Silicon Laboratories in the fourth quarter valued at about $117,000. Finally, KBC Group NV boosted its position in Silicon Laboratories by 42.1% in the fourth quarter. KBC Group NV now owns 1,279 shares of the semiconductor company's stock worth $159,000 after purchasing an additional 379 shares during the last quarter.
Insider Transactions at Silicon Laboratories
In related news, Director William G. Bock sold 2,000 shares of the firm's stock in a transaction on Wednesday, January 22nd. The stock was sold at an average price of $140.77, for a total value of $281,540.00. Following the completion of the sale, the director now directly owns 32,115 shares in the company, valued at $4,520,828.55. This trade represents a 5.86 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Navdeep S. Sooch sold 2,360 shares of the business's stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total transaction of $351,640.00. Following the transaction, the director now owns 400,567 shares in the company, valued at $59,684,483. This trade represents a 0.59 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 5,360 shares of company stock worth $782,610. 1.60% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
SLAB has been the subject of several research reports. Susquehanna assumed coverage on shares of Silicon Laboratories in a research report on Tuesday, December 17th. They set a "neutral" rating and a $130.00 price target for the company. Stifel Nicolaus increased their price target on shares of Silicon Laboratories from $135.00 to $145.00 and gave the stock a "buy" rating in a research report on Monday, January 6th. KeyCorp boosted their price objective on shares of Silicon Laboratories from $115.00 to $160.00 and gave the company an "overweight" rating in a research report on Wednesday, January 22nd. Needham & Company LLC restated a "buy" rating and issued a $150.00 price target on shares of Silicon Laboratories in a research report on Wednesday, March 12th. Finally, StockNews.com downgraded shares of Silicon Laboratories from a "hold" rating to a "sell" rating in a research report on Thursday. One analyst has rated the stock with a sell rating, five have issued a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, Silicon Laboratories has an average rating of "Hold" and an average target price of $136.20.
View Our Latest Stock Analysis on Silicon Laboratories
Silicon Laboratories Stock Down 5.5 %
Silicon Laboratories stock traded down $6.54 during mid-day trading on Friday, reaching $113.03. 340,644 shares of the company's stock traded hands, compared to its average volume of 314,853. Silicon Laboratories Inc. has a 12-month low of $94.00 and a 12-month high of $160.00. The stock has a 50 day moving average of $136.65 and a two-hundred day moving average of $123.65. The company has a market cap of $3.67 billion, a price-to-earnings ratio of -19.03 and a beta of 1.15.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last announced its quarterly earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) EPS for the quarter, meeting analysts' consensus estimates of ($0.11). Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The firm had revenue of $166.25 million during the quarter, compared to the consensus estimate of $166.09 million. During the same quarter last year, the firm earned ($1.19) EPS. The firm's revenue for the quarter was up 91.4% compared to the same quarter last year. As a group, sell-side analysts forecast that Silicon Laboratories Inc. will post -0.97 earnings per share for the current year.
Silicon Laboratories Company Profile
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Featured Articles

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report